Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers

Author:

Rosás-Umbert Miriam12,Llano Anuska1,Bellido Rocío1,Olvera Alex1,Ruiz-Riol Marta1,Rocafort Muntsa1,Fernández Marco A.3,Cobarsi Patricia4,Crespo Manel5,Dorrell Lucy6,del Romero Jorge7,Alcami José8,Paredes Roger1249,Brander Christian191011,Mothe Beatriz149ORCID

Affiliation:

1. IrsiCaixa AIDS Research Institute–HIVACAT, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

2. Universitat Autònoma de Barcelona, Barcelona, Spain

3. Flow Cytometry Facility, Health Sciences Research Institute Germans Trias i Pujol, Badalona, Spain

4. HIV Unit, Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

5. Infectious Diseases Unit, Internal Medicine Department, Complexo Hospitalario Universitario de Vigo, IIS Galicia Sur, Spain

6. Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

7. Centro Sanitario Sandoval, Madrid, Spain

8. Instituto de Salud Carlos III, Madrid, Spain

9. University of Vic and Central Catalonia, UVIC-UCC, Vic, Spain

10. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

11. AELIX Therapeutics, Barcelona, Spain

Abstract

A few individuals can control HIV infection without the need for antiretroviral treatment and are referred to as HIV controllers. We have studied HIV controllers who suddenly lose this ability and present with high in vivo viral replication and decays in their CD4 + T-cell counts to identify potential immune and virological factors that were responsible for initial virus control. We identify in vitro -determined reductions in the ability of CD8 T cells to suppress viral control and the presence of PD-1-expressing CD8 + T cells with a naive immune phenotype as potential predictors of in vivo loss of virus control. The findings could be important for the clinical management of HIV controller individuals, and it may offer an important tool to anticipate viral rebound in individuals in clinical studies that include combination antiretroviral therapy (cART) treatment interruptions and which, if not treated quickly, could pose a significant risk to the trial participants.

Funder

Fundación para la Investigación y la Prevención del Sida en España

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3